Sodium Benzoate/Caffeine

苯甲酸钠/咖啡因

Report date: 2022/01/14 13:23:58

Base Information

Drug NameSodium Benzoate/Caffeine
Drug Alias Name安钠咖片安钠咖注射液
ClassificationSmall molecules
Mechanisms of ActionD-amino-acid oxidase inhibitorsAdenosine A1 receptor antagonistsAdenosine A2a receptor antagonists
TargetsD-amino-acid oxidaseAdenosine A1 receptorAdenosine A2a receptor
Therapy Area/IndicationsCentral Nervous System Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsYes Sodium BenzoateCaffeine
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesN/A
Active IndicationsCentral Nervous System Diseases
Inactive IndicationsN/A

Other Information

ATC CodeV04CG30
Related LinksN/A